Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.68 |
| ▸ | FBP1 | P09467 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | IGF2R | P11717 | 4/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.40 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HK1 | P19367 | 1/20 | 0.40 |
| ▸ | HK2 | P52789 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29394667 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20291477 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL4363197 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20299968 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL4363206 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL25361382 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL14669223 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20912983 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL20558753 | 1.00 | AMDHD2 (0.68) | AMDHD2FBP1MAPK1IGF2RLGALS3 | |
| SCHEMBL14414838 | 0.96 | AMDHD2 (0.62) | AMDHD2FBP1MAPK1IGF2RLGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731778-A2 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-04-29 | — | — | EP | disclosed |
| US-12600997-B2 | Fermentative production of sialylated saccharides | CHR. HANSEN A/S (DK) | 2026-04-14 | — | — | US | disclosed |
| US-20260015636-A1 | ENHANCING FORMATION OF HUMAN MILK OLIGOSACCHARIDES (HMOS) BY MODIFYING LACTOSE IMPORT IN THE CELL | DSM IP ASSETS BV (DK) | 2026-01-15 | — | — | US | disclosed |
| EP-4662305-A1 | PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | disclosed |
| WO-2025224348-A1 | PRODUCTION OF A MILK OLIGOSACCHARIDE MIXTURE | INBIOSE N.V. (BE) | 2025-10-30 | — | — | WO | disclosed |
| US-12344875-B2 | Sialyltransferases for the production of sialylated oligosaccharides | INBIOSE N.V. (BE) | 2025-07-01 | — | — | US | disclosed |
| US-20250188503-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF SIALYLATED OLIGOSACCHARIDES | INBIOSE N.V. (BE) | 2025-06-12 | — | — | US | disclosed |
| WO-2025088103-A1 | PRODUCTION OF A SIALYLATED COMPOUND | INBIOSE N.V. (BE) | 2025-05-01 | — | — | WO | disclosed |
| WO-2025088102-A1 | PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE COMPRISING GAL-β1,3-[NEU5AC-A2,6]-HEXNAC-R | INBIOSE N.V. (BE) | 2025-05-01 | — | — | WO | disclosed |
| US-12286658-B2 | Enhancing formation of milk oligosaccharides (HMOs) by modifying lactose import in the cell | DSM IP ASSETS B.V. (DK) | 2025-04-29 | — | — | US | disclosed |
| CN-115151651-A | Synthesis of glycosylated sphingosine base of interest or analogues thereof | 碳码股份公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-115151650-A | Synthesis of C-glycosides of interest | 碳码股份公司 | 2022-10-04 | — | — | CN | disclosed |
| EP-3467100-B1 | MICROORGANISMS AND METHODS FOR PRODUCING SIALYLATED AND N-ACETYLGLUCOSAMINE-CONTAINING OLIGOSACCHARIDES | Glycosyn LLC (US) | 2022-09-21 | — | — | EP | disclosed |
| US-20220243237-A1 | SIALYLTRANSFERASES AND USES THEREOF | Glycosyn LLC | 2022-08-04 | — | — | US | disclosed |
| WO-2022157280-A1 | NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (FRED) IN PRODUCTION OF SIALYLATED HMOS | GLYCOM A/S (DK) | 2022-07-28 | — | — | WO | disclosed |
| WO-2022152915-A1 | EXTRACELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS | INBIOSE N.V. (BE) | 2022-07-21 | — | — | WO | disclosed |
| WO-2022152914-A1 | CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS | INBIOSE N.V. (BE) | 2022-07-21 | — | — | WO | disclosed |
| WO-2022135700-A1 | SIALYLTRANSFERASES FOR THE PRODUCTION OF 6'-SIALYLLACTOSE | Chr. Hansen HMO GmbH (DE) | 2022-06-30 | — | — | WO | disclosed |
| US-11274325-B2 | Sialyltransferases and uses thereof | Glycosyn LLC (US) | 2022-03-15 | — | — | US | disclosed |
| WO-2022034075-A1 | PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL | INBIOSE N.V. (BE) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015636-A1 | ENHANCING FORMATION OF HUMAN MILK OLIGOSACCHARIDES (HMOS) BY MODIFYING LACTOSE IMPORT IN THE CELL | GALNT2, GALNT1, GALNT10 | AMDHD2 213/4885FBP1 77/4885MAPK1 2013/4885 |
| US-12600997-B2 | Fermentative production of sialylated saccharides | RNGTT, NANS, ENGASE | AMDHD2 122/4885FBP1 30/4885MAPK1 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.